PULSUS invites all the participants across the globe to attend ‘22nd International conference on Cancer Research & Pharmacology’ during November 06-08, 2017 in Madrid, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Cancer Research 2017 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.
Why to attend??
Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.
Who should attend??
Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees.
PULSUS which organizes 1000+ Global events every year is delighted to welcome all the enthusiastic participants across the world to its prestigious Conference on ‘22nd International conference on Cancer Research & Pharmacology’ which is going to be held during November 06-08, 2017 at Madrid, Spain. Cancer Research 2017 highlights the theme “Innovations in Cancer Research”.
PULSUS provides an opportunistic environment and vibrant podium through these auspicious events to amplify these steps and meet the highest demand ever, by reflexive and cerebrative connections. PULSUS has been progressively organizing scientific conferences across the globe, rendezvous which consist of various streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 1000 international conferences per year which is supported by 700 open access journals and 80,000 Editorial Board Members. The number of reader views of the website has clocked 7.5 million and still counting. Lately around more than 1000 scientific associations of various fields from all over the world have shown interest in association with PULSUS to promote their research work. PULSUS conferences offer exciting features like international symposia, B2B meetings, trade shows, exhibitions, and international workshops to build global networking and meaningful academic research and industry alliances. PULSUS initiated the 'Young Scientist awards' to the enterprising young science researchers and scholars across the globe.
Cancer Therapy 2017 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.
The main aim of this conference is Innovations and Novel Approaches in Diagnosis and Treatment of Cancers.
Importance and Scope:
Cancer Therapy 2017 is a unique forum to bring together worldwide distinguished academics in the field of public health professionals, academic scientists, industry researchers, scholars to exchange about the state of the art research and technologies.
Diagnostic Professionals, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals.
Session and Tracks
PULSUS Group is overwhelmed to announce the commencement of “22nd International Conference on Cancer Drugs and Therapeutics” during September 11-12, 2017 in Paris, France. The upcoming conference will be organized around the theme “New era of Cancer Drugs and advances in Therapeutics”.
Cancer Drugs and Therapeutics 2017 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.
Track 1: Cancer Drugs
A Cancer Drugs is an antibody that either treats existing disease or forestalls advancement of a malignancy. Antibodies that regard existing growth are known as restorative malignancy immunizations. Malignancy immunizations help the resistant framework's normal capacity to perceive and annihilate things that are remote and possibly unsafe to the body. A solid, sound resistant framework can distinguish antigens and assault them, ordinarily dispensing with them. A malignancy treatment antibody exploits the resistant framework's reaction to antigens. Regularly, tumor cells have particular particles on their surface that are not present on solid cells. At the point when infused into a man, these particular atoms go about as antigens, which empower the safe framework to perceive and pulverize tumor cells that have these particles on their surface. Most disease antibodies additionally contain adjuvants. Malignancy immunizations are two sorts they are Preventive (or prophylactic) antibodies.
Track 2: Cancer Cell Biology
Cancer Cell Biology, Diagnosis and Applied Research are using cell biological and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. Cancer is a multistep process involving several cell signalling pathways. Membrane proteins are involved in the prognosis of the most common forms of cancer. Membrane proteins are the hallmark of a cancer cell. These overexpressed membrane receptors are becoming increasingly important in cancer cell therapy.
Track 3: Cancer Genomics
Cancer Genomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. The study involves the research in to the Bioinformatics and functional analysis of oncogenes, which refers to the gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels. Cancer genome sequencing requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems.
Metabolomics is a new-born cousin to genomics and proteomics. Specifically, metabolomics involves the rapid, high throughput characterization of the small molecule metabolites found in an organism.
Track 4: Organ-Specific Cancer
Organ Specific Cancers are cancers named basing on the position of cancer in the body organ. Cancer can affect just about every organ in the human body. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012. Lung cancer, also known as carcinoma of the lung or pulmonary carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. There are more than 200 different types of cancer, but Breast cancer, Head & Neck Cancer, Blood, lung and leukemia cancer cancers that are diagnosed with the greatest frequency. Cancer genetics is now one of the fastest expanding medical specialties. However, some people inherit mutation in the germ line. The mutations occur in two classes of cellular genes: oncogenes and tumor suppressor genes. Breast cancer is the most common type of cancer among women.
Track 5: Anti-carcinogens
Anti-carcinogens are different from anti-carcinoma agents in that anti-carcinoma agents are used to selectively destroy or inhibit cancer cells after cancer has developed. Advances in analytical methods and recombinant DNA technology contributed greatly to the study of metabolism of chemical carcinogens. Major advances have been made in the assignment of roles of individual enzymes in reactions. Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. Cancer research is basic research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure. Carcinogenesis is the actual formation of a cancer, whereby normal cells are transformed into cancer cells. The main carcinogenic factors can be grouped into: primary determining factors; secondary determining factors, and favouring factors. Different types of non-ionizing and ionizing radiations are major factors in the mechanisms of carcinogenesis. Chemical carcinogenic substances are first activated through the hepatic microsomal system, and then they bind in a covalent form to the macromolecules (DNA, RNA, proteins) from the target organs.
Track 6: Anti-cancer drug and delivery
Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Tissue-specific gene delivery using immune liposomes has also been achieved in brain, and breast cancer tissue. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. The use of nanotechnology in cancer treatment offers some exciting possibilities, including the possibility of destroying cancer tumors with minimal damage to healthy tissue and organs, as well as the detection and elimination of cancer cells before they form tumors.
Track 7: Cancer Diagnosis and Applied Research
Cancer Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. At Cancer Treatment Centres, we use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan. Some cancers are diagnosed during routine screening examinations. These are usually tests that are routinely done at a certain age. Many cancers are discovered when you present to your health care professional with specific symptoms.
Track 8: Advances in malignancy counteractive action and screening
Malignancy is most familiar as a characterization of cancer. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Small molecules are usually designed to interfere with the enzymatic activity of the target protein. Most of this tumour occurs in people over the age of 60. Due to the numerous roles of p53 in genomic stability and its defects in many human cancers, therapeutic agents that restore p53 activity in tumors are the subject of multiple clinical trials. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.
Track 9: Experimental Cancer Treatments
Experimental cancer treatments are medical therapies intended or claimed to treat cancer by improving on, supplementing or replacing conventional methods (surgery, chemotherapy, radiation, and immunotherapy). Oncolytic virotherapy is an exciting, increasingly recognized discipline in cancer research. The recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Sievert events deal with the sievert is a derived unit of ionizing radiation dose in the International System of Units (SI). It is a measure of the health effect of low levels of ionizing radiation on the human body. Quantities that are measured in sieverts are intended to represent the stochastic health risk, which for radiation dose assessment is defined as the probability of cancer induction and genetic damage.
Track 10: Cancer prognosis
Cancer survival rates or survival statistics tell the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate. Cancer survival rates are supported on research from information gathered on hundreds or thousands of individual with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with cancer, together with those diagnosed terribly early and people diagnosed terribly late
Track 11: Ayurvedic Treatment for Cancer
Ayurvedic medicine will focus on advice on diet and special diets, Taking specific Ayurvedic medications, Herbal medicine, Massage, Meditation, Yoga and Breathing and relaxation techniques. People with cancer usually prefer touch therapies such as massage and aromatherapy. Blood carcinoma is one of the major cancer that affect mainly blood, bone marrow, lymph and lymphatic system for treating this recent techniques have been discovered by the researchers through targeting the tumor and restrict their growth. A larger section of individuals say these therapies help them to cope better with cancer and its treatment. Research is looking into whether some herbs or plant treatments used in Ayurvedic medicine can prevent or treat cancer. Oncology Nursing conferences is the upcoming conference in which nursing techniques are been discussed as there are limited educational program in oncology nursing this will be the best platform to share ideas. Some herbal treatments may affect the way cancer drugs are broken down by the human body or the way drugs are transported around human body.
Track 12: Carcinoma Adenocarcinoma
Carcinoma is a type of cancer which will be developed from epithelial cells. Especially, a carcinoma is a cancer which begins in a tissue that lines the inner or outer surfaces of the body, and that generally arises from cells in the endodermal or ectodermal germ layer during embryogenesis. Cancer affects when a single progenitor cell accumulates mutations and changes in the DNA, histones, and other biochemical compounds which make the cell's genome. The cell genome regulates the structure of the cell's biochemical components, the biochemical reactions that generally occur within the cell, and the biological interactions of that cell with other cells. Osteosarcoma conferences deal with an osteosarcoma which is a cancerous tumor in bone. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in children and young adults.
Track 13: Cancer Immunotherapy
Biologic Response Modifiers (BRM), also called immunotherapy, is a type of treatment that mobilizes the body's immune system to fight cancer. The therapy mainly consists of stimulating the immune system to help it do its job more effectively. Tumor Vaccines also work to stimulate the body's immune system.
Track 14: Stem cell therapy
Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps in transplanting immature microorganisms or giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of body part is not really another idea.
Track 15: Chemotherapy
Chemotherapy is a kind of cancer treatment that uses drug to destroy cancer cells. Chemotherapy works by slowing down the growth of cancer cells which grow and divide quickly. But it can also harm healthy cells that divide too quickly. Chemotherapy process can cure cancer, control cancer and ease cancer symptoms.
Track 16: Radiation therapy
Radiation therapy kills cancer cells by damaging their DNA (the molecules inside cells that carry genetic information and pass it from one generation to the next). Radiation therapy can either damage DNA directly or create charged particles (free radicals) within the cells that can in turn damage the DNA. Cancer cells whose DNA is damaged beyond repair stop dividing or die. When the damaged cells die, they are broken down and eliminated by the body’s natural processes. However it can damage normal cells also. The amount of radiation that normal tissue can safely receive is known for all parts of the body. Doctors use this information to help them decide where to aim radiation during treatment.
Track 17: Gene Therapy
Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes for the genes. Cell therapy is expanding its repertoire of cell types for administration. Cell therapy treatment strategies include isolation and transfer of specific stem cell populations, administration of effector cells, and induction of mature cells to become pluripotent cells, and reprogramming of mature cell
Track 18: Complementary and Alternative Medicine
Complementary and alternative medicine is also known as CAM. CAM therapies include a wide variety of botanicals and nutritional products, such as dietary supplements, herbal supplements, and vitamins. Many of these "natural" products are considered to be safe because they are present in, or produced by, nature. However, that is not true in all cases. In addition, some may affect how well other medicines work in your body.
There is research to show that some Complementary and alternative medicine techniques can help with problems like pain and nausea. But other therapies don't have enough medical evidence to decide if they are effective.
Track 19: Socioeconomic impact of cancer
The financial costs of cancer are very high for both the person with cancer and for society as a total. The Agency for Healthcare research and Quality (AHRQ) estimates that the direct medical costs (total of all health care costs) for cancer in the US in 2011 were $88.7 billion. And according to Cancer Facts & Figures 2015, “Uninsured patients and those from ethnic minorities are substantially more likely to be diagnosed with cancer at a later stage, when treatment can be more extensive, more costly, and less successful.” The Oncology exhibitions are the best platform to exhibit oncology related products.
Track 20: Novel Approaches to Cancer Therapeutics
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer. Despite the fact that new technologies and strategies often fail to identify well-established cancer biomarkers and show a bias toward the identification of high-abundance molecules, these technological advances have the capacity to revolutionize biomarker discovery. The study of the tumor metabolism describes the different characteristic metabolic changes in tumor cells. The emerging field of metabolomics– which attempts to profile all metabolites within a cell or biological system – is now being used to analyse cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. While a large fraction of cancer metabolomics research is focused on finding diagnostic biomarkers, metabolomics is also being used to obtain more fundamental mechanistic insight into cancer and carcinogenesis. PULSUS is delighted to organize radiation oncology conference in upcoming year which discuss about radiation techniques.
European Oncology Conference help researchers learn more about cancer, they’re developing new therapies that target particular types of tumor cells and restrict their growth. On their own or in combination with other alternative treatments, these therapies can decrease the size of tumors and symptoms. Some innovative therapies give hope for people with cancers that have been resistant to more treatments. There are different stages of the cancer like Stage 1, Stage 2, Stage 3 and Stage 4. Translation cell carcinoma is an implication of translational techniques for cancer treatment where new treatments can be developed.